1. Home
  2. ICD-10-PCS
  3. XY0YX37
  4. Share
  5. Feedback

ICD 10 Code XY0YX37

Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
“Extracorporeal Introduction of Nafamostat, New Tech 7” for short

XY0YX37 is a valid billable ICD-10 procedure code for Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7. It is found in the 2025 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025.

Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

External approach involves:
Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane

Nafamostat Anticoagulant device includes:

  • LTX Regional Anticoagulant
  • Niyad(tm)

ICD-10-PCS code structure for XY0YX37 — See Table View

1: Section X New Technology
2: Body System Y Extracorporeal
3: Root Operation 0 Introduction
4: Body Part Y Extracorporeal
5: Approach X External
6: Device 3 Nafamostat Anticoagulant
7: Qualifier 7 New Technology Group 7

See also

  • The ICD-10-PCS Index of common procedure terms.
  • New Technology terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.